의약품 관련 법령
Clarification Note 003/2017/GPBIO/GGMED/ANVISA: Interchangeability between Biosimilars and Comparator Biological Products
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-10-31 | 조회수 | 852 |
국가정보 | 남 아메리카>브라질 | ||
출처 | ANVISA | ||
원문 | http://portal.anvisa.gov.br/ | ||
첨부파일 |
Clarification Note 003/2017/GPBIO/GGMED/ANVISA: Interchangeability between Biosimilars and Comparator Biological Products
- 이전글 Questions and Answers: Registration Procedure for Industrialized Dynamized Medicinal Products
- 다음글 Guidelines: Presentation of Planning of Applications for Effective Marketing Authorization of Biological Medicinal Products and Radiopharmaceuticals (FORM PAEC-B 1.1)